All results
186 results for tests
-
AEVI-007
The main purpose of the study is to evaluate the safety and tolerability of Camoteskimab in participants with Still's Disease. ### Inclusion Criteria: 1.…
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
AIM2ACT
The aim is to test the efficacy of AIM2ACT and long-term maintenance of treatment effects in a fully-powered randomized controlled trial with 160 early…
- Ages
- 12 Years - 70 Years
- Sexes
- All
-
ANCHORS: UH3
80 young adult men will complete an initial survey and receive 1 of 2 types of alcohol and sexual health education and information to encourage prevention of…
- Ages
- 18 Years - 30 Years
- Sexes
- Male
-
APL2-C3G-314
This study is designed as a long-term extension to Study APL2-C3G-310, and is being conducted to establish the long-term safety and efficacy of pegcetacoplan…
- Ages
- 12 Years - N/A
- Sexes
- All
-
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
The APOLLO study is being done in an attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation based upon…
- Ages
- N/A - N/A
- Sexes
- All
-
ARGX-113-2007
This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory Myopathy…
- Ages
- 18 Years - N/A
- Sexes
- All
-
ATB200-08
This is a Phase 3, open-label, multicenter study to evaluate the safety, efficacy, PK, PD, and immunogenicity of cipaglucosidase alfa/miglustat treatment in…
- Ages
- N/A - 17 Years
- Sexes
- All
-
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
In parallel with the growth of American Thrombosis and Hemostasis Network's (ATHN) clinical studies, the number of new therapies for all congenital and…
- Ages
- N/A - N/A
- Sexes
- All
-
Abbott Next Generation Drug Eluting Stent 48mm Study (ABT NG DES 48)
The purpose of this SPIRIT 48 study is to evaluate the safety and effectiveness of the ABT NG DES 48 in improving coronary artery luminal diameter in subjects…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Adaptive COVID-19 Treatment Trial (ACTT)
This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized…
- Ages
- 18 Years - 99 Years
- Sexes
- All